Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | HIV/AIDS Clinical Trials in Chicago | 130 Studies

Clinical Trials HIV/AIDSChicago

HIV/AIDS Clinical Trials in Chicago

Find 130 clinical trials for hiv/aids near Chicago, Illinois. Connect with research centers in your area.

All HIV/AIDS trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 130 trials

CompletedEvaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV InfectionHepatitis C virus (HCV) infection is a leading cause of death and illness in people with HIV-1.NCT01482767·Birmingham, Alabama and 42 others

HIV/AIDS Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

RecruitingA Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)Researchers are looking for new ways to treat HIV-1 (Human Immunodeficiency Virus Type 1).NCT07266831·Los Angeles, California and 54 others

CompletedGRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men.The purpose of this study is to evaluate any differences in the effectiveness, safety, and tolerability of PREZISTA (darunavir; DRV) 600 mg, administered with ritonavir (RTV) 100…NCT00381303·Birmingham, Alabama and 45 others

CompletedRitonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.The purpose of this study is to evaluate the non-inferiority of ritonavir-boosted GS-9137 relative to a ritonavir-boosted Comparator Protease Inhibitor when used as part of…NCT00298350·Phoenix, Arizona and 53 others

CompletedThe Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected WomenThe purpose of this study is to see how often human papillomavirus (HPV) occurs in HIV-infected women who have not taken anti-HIV drugs and to learn whether taking anti-HIV drugs…NCT00006444·Birmingham, Alabama and 50 others

CompletedTMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.The purpose of this trial is to compare the effectiveness, safety and tolerability of TMC278 given at a dose of 25 mg once daily versus efavirenz (EFV) at a dose of 600 mg once…NCT00540449·Birmingham, Alabama and 91 others

CompletedEvaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody (VRC01) on Markers of HIV Persistence in HIV-Infected Adults Receiving Antiretroviral Therapy (ART)The purpose of this study was to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody (mAb), VRC-HIVMAB060-00-AB (VRC01), in adults infected…NCT02411539·San Diego, California and 12 others

CompletedSafety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected WomenHuman papillomavirus (HPV) is the most common sexually transmitted disease in the world.NCT00604175·Birmingham, Alabama and 60 others

CompletedEfficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 CoinfectionThe primary objectives of this study are to evaluate the efficacy, safety and tolerability of treatment with sofosbuvir/velpatasvir (SOF/VEL) for 12 weeks in participants with…NCT02480712·Birmingham, Alabama and 14 others

CompletedStudy of the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive AdultsThe objective of this double-blinded, multicenter, randomized, active-controlled study is to evaluate the safety and efficacy of Stribild, a single-tablet regimen (STR) containing…NCT00869557·Little Rock, Arkansas and 29 others

CompletedA Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial)The purpose of this trial is to assess the non-inferior antiviral activity of GSK1349572 50 mg plus Abacavir/Lamivudine once daily versus Efavirenz/Emtricitabine/Tenofovir…NCT01263015·Hobson City, Alabama and 144 others

CompletedThe Safety and Effectiveness of Zidovudine Plus Acyclovir in Patients With Early HIV InfectionThis double-blind, placebo-controlled study is designed to determine the long-term safety and efficacy of concurrent oral Retrovir / Zovirax (AZT and ACV) therapy and oral AZT…NCT00002290·Birmingham, Alabama and 13 others

CompletedA Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral RegimenThis study is a 48-week, Phase IIIb, randomly assigned, open-label, active-controlled, multicenter, parallel group, non-inferiority study.NCT02105987·Phoenix, Arizona and 102 others

CompletedPegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)Infection with both HIV and hepatitis C virus (HCV) may result in serious and sometimes fatal liver disease.NCT00078403·Birmingham, Alabama and 36 others

CompletedA Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant WomenThe purpose of this study is to study how changes in the body during pregnancy influence the blood levels of TMC114 (darunavir) and ritonavir taken together, darunavir and…NCT00855335·Daytona Beach, Florida and 16 others

Active not recruitingEfficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected AdultsThis Antiretroviral Therapy as Long Acting Suppression every 2 Months (ATLAS-2M) study is designed to demonstrate the non-inferior antiviral activity and safety of CAB LA + RPV LA…NCT03299049·Birmingham, Alabama and 118 others

CompletedTreatment of Oral Warts in HIV+ PatientsThis is a study to test lozenges of interferon-alpha that are dissolved in the mouth as a treatment of oral warts in HIV-positive adults.NCT00454181·San Francisco, California and 11 others

TerminatedStudy Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected SubjectsThe purpose of this study is to evaluate the safety and efficacy of the CCR5 antagonist GW873140 or placebo in combination with an optimized background regimen in…NCT00197145·Birmingham, Alabama and 54 others

CompletedEffects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIVThe purpose of this study is to find out whether these powerful combinations of anti-HIV drugs are safe and effective for use in patients in the early stages of HIV infection and…NCT00001119·San Francisco, California and 11 others

CompletedInterleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV CoinfectionThis study will test the safety and effectiveness of a new treatment for hepatitis C (HCV) in patients who also have HIV.NCT00015652·Los Angeles, California and 7 others

PreviousPage 3 of 7Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia